CSIMarket
 
Nrx Pharmaceuticals Inc   (NRXP)
Other Ticker:  
 
 

Nrx Pharmaceuticals Inc Balance Sheet Quarterly

NRXP


Select the Financial Report:   Period:   Fiscal Year:




NRXP Balance Sheets
(Quarterly, GAAP in millions $)

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
ASSETS
Cash & cash equivalent 8.90 14.97 16.51 20.05 18.25
Cash, Cash Eqvivalents Other - - - - -
Cash & Short-term Investments 8.90 14.97 16.51 20.05 18.25
Accounts receivable - - - - -
Other Receivables - - - - -
Notes Receivable, Current - - - - -
Inventories - - - - -
Other Current Assets 0.00 - - 0.00 -
Prepaid Expense And Other Assets Current 4.19 4.82 5.25 5.74 6.55
Total Current Assets 13.09 19.79 21.76 25.80 24.80
Equipment/Property/Plant Net - - - - -
Goodwill net - - - - -
Intangible Assets - - - - -
Long-term investments - - - - -
Accounts Receivable, Net, Noncurrent - - - - -
Financial Instruments - - - - -
Tax Assets, Noncurrent - - - - -
Other Assets, Noncurrent 0.02 0.02 0.02 0.02 0.02
Deferred, Prepaid and Other Assets, Noncurrent - - - - -
Discontinued operations, Noncurrent - - - - -
Total Assets 13.11 19.81 21.78 25.82 24.82
LIABILITIES
Accounts Payable, Current AC 3.63 2.21 3.78 2.08 2.17
Accrued Liabilities, Current AC 4.73 5.78 5.05 4.86 5.07
Derivative Liability, Current DE 0.01 0.04 0.03 0.04 -
Shortterm Debt - - - - -
Other Liabilities, Current 10.96 14.59 13.21 8.62 -
Taxes Payable - - - - -
Deferred Liability and Revenue - - - - -
Business Combination, Contingent Consideration, Liability, Current BU - - - - -
NotesPayableAndAccruedInterestNonCurrent - - - 2.82 -
Accrued Clinical Site Costs 0.58 1.12 1.02 0.91 0.75
Contract With Customer Liability Current - - - - 0.06
Notes Payable And Accrued Interest Current - - - - -
Accrued Settlement Expense - - - - -
Total Current Liabilities 19.33 22.62 22.06 15.59 7.24
Long-term debt - - - - -
Capital Lease and Other - - - - -
Long-term Debt Convertible - - - - -
Total Long-term Debt - - - - -
Financial Instruments, Insurance, Noncurrent - - - - -
Employee Benefit Plans, Noncurrent - - - - -
Deferred credits, Noncurrent - - - - -
Accrued Income Taxes, Noncurrent - - - - -
Discontinued Operation, Liabilities, Noncurrent - - - - -
Other liabilities, Noncurrent - - - 2.82 8.04
Total Liabilities 19.33 22.62 22.06 18.41 8.04
SHAREHOLDER'S EQUITY
Common Stock Value 0.08 0.08 0.07 0.07 0.07
Additional Paid In Capital Common Stock 242.53 239.89 233.58 230.34 229.47
Retained Earnings / Accumulated Deficit -248.82 -242.75 -234.04 -223.00 -212.76
Other Equity -0.02 -0.02 0.11 0.00 0.00
Common Stockholder's Equity -6.22 -2.81 -0.28 7.41 16.78
Preferred Stockholder's Equity 0.00 - - - -
Noncontrolling interests & other - - - - -
Total Stockholder's Equity -6.22 -2.81 -0.28 7.41 16.78
Liabilities & Stockholder's Equity 13.11 19.81 21.78 25.82 24.82






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com